3745 Sodium/Calcium exchanger
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Hydrocarbons | 1 | 0.0 | 48× | not tested | |
| Phenylpropanoids and polyketides | 1 | 0.1 | 16× | not tested | |
| Lipids and lipid-like molecules | 3 | 0.3 | 9.11× | not tested | |
| Homogeneous non-metal compounds | 2 | 0.6 | 3.14× | not tested | |
| Homogeneous metal compounds | 3 | 1.5 | 2.07× | not tested | |
| Organic oxygen compounds | 1 | 0.6 | 1.70× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02343 | P3G | 3,6,9,12,15-Pentaoxaheptadecane | 1 |
| DB02375 | MYC | Myricetin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 18 |
| MYS | PENTADECANE | 17 |
| CAmetal | CALCIUM ION | 13 |
| NAmetal | SODIUM ION | 11 |
| CL | CHLORIDE ION | 5 |
| SRmetal | STRONTIUM ION | 5 |
| IOD | IODIDE ION | 2 |
| MNmetal | MANGANESE (II) ION | 2 |
| OLA | OLEIC ACID | 2 |
| CDmetal | CADMIUM ION | 1 |
| OLB | (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 1 |
| P3G | 3,6,9,12,15-PENTAOXAHEPTADECANE | 1 |
| TOE | 2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXYL | 1 |